Academic Journal
Q1Eye (Basingstoke)
About Eye (Basingstoke)
About Eye (Basingstoke)
Eye (Basingstoke) is a peer-reviewed scholarly journal published by Springer Nature (United Kingdom). It focuses on Q1. Publication coverage spans 1987-2026.
Key indicators: ISSN 0950-222X, 1476-5454; H-index 140.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (140): Exceptionally high — 140 articles have each been cited at least 140 times. This indicates deep, sustained influence in the field.
Publishing in Eye (Basingstoke)
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Eye (Basingstoke)?
0950-222X, 1476-5454.
Who publishes Eye (Basingstoke)?
Springer Nature.
What are Eye (Basingstoke)'s metrics?
H-index 140.
Where do I submit to Eye (Basingstoke)?
Via the official website.
Is Eye (Basingstoke) peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Retinal Diseases and Treatments; Glaucoma and retinal disorders; Intraocular Surgery and Lenses; Retinal and Macular Surgery; Ophthalmology and Visual Impairment Studies; Corneal surgery and disorders.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,590.00 USD; 5,290.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Personalised ILM peeling for Myopic traction maculopathy
Kengo Uramoto, Tomonari Takahashi, Keigo Sugisawa, Hiroyuki Takahashi et al.
2026-10-15 · DOI: 10.1038/s41433-026-04934-ySelf-administered intraocular injection of tattoo ink resulting in retinotoxicity and secondary glaucoma
Doa’a Kerwat, Rashid Zia, Hardeep Singh Mudhar, Omar A. Mahroo et al.
2026-10-14 · DOI: 10.1038/s41433-026-04979-zFavourable response to photodynamic therapy in patients with stellate multiform amelanotic choroidopathy
Mingzhi Su, Weixin Zheng, Ningxi Hong, Fang Zheng et al.
2026-10-13 · DOI: 10.1038/s41433-026-04960-wAnterior graft displacement as a cause of late Descemet’s membrane detachment after penetrating keratoplasty: a graft-preserving surgical approach
Arnaud Gaulier, Hélène Py, Isabelle Orignac, Marc Muraine et al.
2026-10-13 · DOI: 10.1038/s41433-026-04953-9Decoding choroidal hemangioma: insights from multimodal imaging
Aiswarya Ramachandran, Sahil Kumar
2026-10-13 · DOI: 10.1038/s41433-026-04736-2Blood-cored mutton-fat keratic precipitates in an immunosuppressed child after liver transplantation
Jiabei Xiong, Jiayin Cai, Jian Li
2026-10-12 · DOI: 10.1038/s41433-026-04889-0Macula stretched beyond recognition: bilateral giant macular retinoschisis with stellate retinal remodelling
MounikaReddy Puthalapattu, Eshwar Rajesh, Vignesh T. P.
2026-10-12 · DOI: 10.1038/s41433-026-04924-0Postoperative visual acuity: an appropriate measure of cataract surgical failure, but no longer for success?
John Burkland, Nicholas Woo, John Buchan, Michael Burdon et al.
2026-10-12 · DOI: 10.1038/s41433-026-04973-5Global health training in North American ophthalmology residency programs: a cross-sectional study
Haaris M. Khan, Parsa Khatami, Arvin Zaker, Sophie Sajjadi et al.
2026-10-10 · DOI: 10.1038/s41433-026-04951-xPrelaminar hyperreflective lines in non-arteritic anterior ischaemic optic neuropathy
Anas Alkhabaz, Bianca Chan, Yulan Ren, Rishita Rama Pujari et al.
2026-10-09 · DOI: 10.1038/s41433-026-04954-8Pneumatic retinopexy identification in electronic medical records using an on-premises large language model
James Tsimiklis, Shrirajh Satheakeerthy, Jai Paris, Weng Onn Chan et al.
2026-10-09 · DOI: 10.1038/s41433-026-04958-4Large language models as internal consistency checkers for ophthalmic manuscripts
Ethan La, Jai Paris, Ayushi Agarwal, Weng Onn Chan et al.
2026-10-09 · DOI: 10.1038/s41433-026-04965-5Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial)
Shamika Gune, Mel Rabena, Ashwini Bobbala
2026-10-08 · DOI: 10.1038/s41433-026-04840-3Combined limbal dysmaturation and microcyst like epithelial changes with corneal nerve alterations of a novel anti nectin-4-MMAE antibody drug conjugate
Marwa Deiri, Rafael Boucher, Cédric Pobel, Jacopo Uliano et al.
2026-10-08 · DOI: 10.1038/s41433-026-04976-2MOG-associated optic neuritis in a 4-year-old child presenting with papillary and preretinal haemorrhages
Matheus Almeida, Rutika Dodeja
2026-10-08 · DOI: 10.1038/s41433-026-04905-3Post-treatment residual masses in orbital lymphoma: incidence, risk factors, and prognostic impact
Yeong A Choi, Min Kyu Yang, Ho-Seok Sa
2026-10-08 · DOI: 10.1038/s41433-026-04918-yRapid asymmetric cataract progression in patients following GLP-1 receptor agonist therapy: case series
Mahmoud Eissa, Abdullah Hassan, Mohamed Osman, Omar Mehana et al.
2026-10-07 · DOI: 10.1038/s41433-026-04971-7Deep learning–based prediction of one-year functional and structural outcomes in treatment-naïve DMO after anti-VEGF therapy
Lorena Ulla, Jonathan D. Oakley, Riccardo Fasana, Daniel B. Russakoff et al.
2026-10-07 · DOI: 10.1038/s41433-026-04898-zFacial palsy buccinator synkinesis-related medial lower eyelid contractions: an under-recognised cause of epiphora treatable with botulinum toxin
Simerdip Kaur, Catriona Neville, Mohammad Javed Ali, Raman Malhotra et al.
2026-10-07 · DOI: 10.1038/s41433-026-04968-2Historical controls and modelled costs cannot support first-line amniotic membrane for persistent epithelial defects
Jeremy Kassissieh
2026-10-07 · DOI: 10.1038/s41433-026-04946-8Reviews
Community Reviews
Version History
October 9, 2026 at 7:56 pm
September 25, 2026